| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 121,123 | 121,981 | 128,092 | 121,424 | | Cost of Revenue | 48,006 | 79,621 | 83,466 | 21,442 | | | Gross Profit | 73,117 | 42,360 | 44,626 | 99,982 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 43,467 | 11,362 | 10,293 | 68,610 | | Non Recurring | 130 | 74 | 107 | 13,100 | | Others | 24,227 | 26,258 | 27,105 | 29,412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,293 | 4,666 | 7,121 | (11,140) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (516) | 141 | 8,929 | 231 | | Earnings Before Interest And Taxes | 4,777 | 4,807 | 16,050 | (10,909) | | Interest Expense | 9,521 | 9,812 | 9,881 | 10,552 | | Income Before Tax | (4,744) | (5,005) | 6,169 | (21,461) | | Income Tax Expense | 238 | 208 | 211 | 207 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,310 | (5,213) | 5,958 | (21,668) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,982) | (5,213) | 5,958 | (21,668) | | Preferred Stock And Other Adjustments | (1,645) | (32) |
-
|
-
| | | Net Income Applicable To Common Shares | ($6,627) | ($5,245) | $5,958 | ($21,668) |
|
0.26% Nasdaq 
0.08 (1.45%) 
Income Statement
